Bhutan vs Sweden: The number of people with susceptibility test result for rifampicin
Bhutan
96.77
in 2021
Sweden
96.65
in 2021
Bhutan rank
40th
Sweden rank
42nd
The number of people with susceptibility test result for rifampicin over time
- Bhutan
- Sweden
How they compare
Bhutan currently reports 96.77 against 96.65 in Sweden, a difference of 0.12.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Sweden ahead.
Bhutan ranks 40th and Sweden ranks 42nd of 146 countries.
Across the 2 decades both report, Bhutan averaged higher in 1 and Sweden in 1.
Head to head by decade
| Decade | Bhutan | Sweden | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 93.89 | 97.51 | 3.62 | Sweden |
| 2020s | 98.38 | 96.61 | 1.77 | Bhutan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Bhutan or Sweden?
- Bhutan, at 96.77 against 96.65 in Sweden as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Bhutan and Sweden?
- 0.12, with Bhutan ahead.
- How many years of comparable data are there for Bhutan and Sweden?
- 5 years are reported by both, from 2017 to 2021.
- How do Bhutan and Sweden rank globally for the number of people with susceptibility test result for rifampicin?
- Bhutan ranks 40th and Sweden ranks 42nd of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.